AFFLUENT MEDICAL press release
Financial results for the first half of 2022 and significant progress in 2022.
– Excellent interim results from the pivotal Optimise II study for the KaliosTM mitral annulus
– Appointment of Sébastien Ladet, who is leaving Medtronic for Affluent Medical, as Chief Executive Officer
– Success of the capital increase with maintenance of DPS
– Appointment of Michel Therin as new Director
– Appointment of Christophe Giot as Vice-President of Clinical Affairs